DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 01 · Volume 24 · February 1998 DOI: 10.1055/s-002-7268

  • 1
    Mammen, Eberhard F.:

    Preface

  • 3
    Bick, Rodger L.:

    Disseminated Intravascular Coagulation: Pathophysiological Mechanisms and Manifestations

  • 19
    Mammen, Eberhard F.:

    Antithrombin: Its Physiological Importance and Role in DIC

  • 27
    Okajima, Kenji; Uchiba, Mitsuhiro:

    The Anti-Inflammatory Properties of Antithrombin III: New Therapeutic Implications

  • 33
    Vervloet, Marc G.; Thijs, Lambertus G.; Hack, C. Erik:

    Derangements of Coagulation and Fibrinolysis in Critically III Patients with Sepsis and Septic Shock

  • 45
    Penner, John A.:

    Disseminated Intravascular Coagulation in Patients with Multiple Organ Failure of Non-Septic Origin

  • 53
    Riewald, Matthias; Riess, Hanno:

    Treatment Options for Clinically Recognized Disseminated Intravascular Coagulation

  • 61
    Dickneite, Gerhard:

    Antithrombin III in Animal Models of Sepsis and Organ Failure

  • 71
    Eisele, Bernd; Lamy, Maurice:

    Clinical Experience with Antithrombin III Concentrates in Critically III Patients with Sepsis and Multiple Organ Failure

  • 81
    Schuster, Hans-Peter:

    Epilogue: Disseminated Intravascular Coagulation and Antithrombin III in Intensive Care Medicine: Pathophysiological Insights and Therapeutic Hopes